Ambase CORP

Market Movers (8-K)

OTC.Pink
AmBase Corporation announced an additional $1 million in litigation funding from CEO Richard A. Bianco, bringing the total to $7 million, to support working capital and ongoing legal expenses related to the 111 West 57th Property.
Capital raise
OTC.Pink
AmBase Corporation reports the successful re-election of director Richard A. Bianco and advisory approval of executive compensation at its 2026 annual meeting.
OTC.Pink
AmBase Corporation has secured $6 million in litigation funding from its CEO and converted $2 million in debt from BARC Investments to continue its 111 West 57th Property litigation, addressing its going concern qualification.
Worse than expected
Capital raise
OTC.Pink
AmBase Corporation obtained a $300,000 loan from its Chairman and CEO, Richard A. Bianco, to support working capital and ongoing litigation efforts.
Capital raise
OTC.Pink
AmBase Corporation has entered into a $100,000 senior promissory note with its Chairman, President, and CEO, Richard A. Bianco, to secure working capital and support ongoing litigation.
Capital raise
Worse than expected
OTC.Pink
AmBase Corporation reported that Joseph R. Bianco ceased employment with the company effective January 1, 2026.

Quarterly Earnings (10-Q)

OTC.Pink
AmBase Corporation filed its Q1 2026 10-Q, detailing a net loss of $775,000 and highlighting significant ongoing litigation related to its 111 West 57th Property investment.
Capital raise
Worse than expected
OTC.Pink
AmBase Corporation reports continued net losses and significant going concern doubt, with its future heavily reliant on the outcome of complex, long-running litigation over a New York real estate investment.
Delay expected
Worse than expected
Capital raise
OTC.Pink
AmBase Corporation reported reduced net losses in Q2 2025, driven by lower operating expenses and a tax credit refund, while facing substantial doubt about its ability to continue as a going concern due to ongoing, costly litigation over its 111 West 57th Property investment.
Capital raise
Worse than expected
OTC.Pink
AmBase Corporation reports a net loss for Q1 2025 while navigating ongoing litigation related to the 111 West 57th Property and facing substantial doubt about its ability to continue as a going concern.
Worse than expected
Capital raise
OTC.Pink
AmBase Corporation reported a net loss for the third quarter of 2024, while continuing to navigate complex litigation and financial challenges.
Worse than expected
Capital raise
OTC.Pink
AmBase Corporation reported a net loss for the second quarter of 2024, while navigating complex litigation and concerns about its ability to continue as a going concern.
Worse than expected
Capital raise

Annual Reports (10-K)

OTC.Pink
AmBase Corporation's 2024 10-K filing reveals ongoing operating losses, substantial doubt about its ability to continue as a going concern, and continued legal battles surrounding its investment in the 111 West 57th Property.
Capital raise
Worse than expected
OTC.Pink
AmBase Corporation's 2023 annual report reveals a net loss of $5.271 million and substantial doubt about the company's ability to continue as a going concern, primarily due to ongoing litigation related to a real estate investment.
Capital raise
Worse than expected

Insider Trading (Form 4)

OTC.Pink
Barc Investments LLC acquired 909,691 shares of AmBase Corp at $0.21 per share in a private transaction, increasing its direct holdings to 59,860,151 shares.
OTC.Pink
Director Jerry Y. Carnegie files a Form 4 indicating changes in beneficial ownership of AmBase Corp securities.
OTC.Pink
Barc Investments LLC has committed to purchase up to 44,200,460 shares of AmBase Corp's common stock through a Standby Purchase Agreement, potentially increasing its holdings to 60,200,460 shares.
Capital raise

Proxy Statements (Def-14A)

OTC.Pink
AmBase Corporation announces its 2026 Annual Meeting to elect a director, approve executive compensation, and details ongoing litigation funding.
Capital raise
OTC.Pink
AmBase Corporation has replaced its independent auditor from Marcum LLP to CBIZ CPAs following Marcum's acquisition by CBIZ CPAs, leading to the removal of the auditor ratification proposal from the upcoming annual meeting agenda.
OTC.Pink
AmBase Corporation will hold its 2025 Annual Meeting of Stockholders on June 6, 2025, to elect directors and ratify the appointment of its independent accounting firm.
Capital raise
OTC.Pink
Ambase Corporation has filed a definitive proxy statement with the Securities and Exchange Commission.
OTC.Pink
AmBase Corporation is holding its annual meeting on June 4, 2024, to vote on the election of a director, ratification of the company's accounting firm, and a proposal to increase the number of authorized common shares from 85 million to 200 million.
Capital raise